"Degollaron a todos los dichos treynta e tres yngleses e asy degollados dis que los lançaron en la mar": Las hermandades vascas y la lucha contra la piratería en la Baja Edad Media

[ES]En este artículo se analizan las acciones de piratería y de corso sufridas o protagonizadas por naturales del País Vasco en el siglo XV. Igualmente se analiza la concesión de cartas de marca y represalia para resarcirse de las acciones piráticas. Y, por último, la persecución de la pirtaería por parte de las autoridades de la provincia de Guipúzcoa, a través de la institución de la Hermamdad, mediante el ejemplo de un buque inglés capturado por piratas vascos.

Del boceto al objeto a través del BIT en la obra "La materia del tiempo", de Richard Serra

423 p.

CDA, Una start-up en el sector del mar

El proyecto consiste en un plan de empresa actualizado para la empresa Commercial Diving Activities, S.L . Es una empresa de obras y servicios integrales de buceo comercial que cuenta con una división dedicada a la formación de buceo profesional.

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

Lymphangioleiomyomatosis (LAM) is a rare lung-metastasizing neoplasm caused by the proliferation of smooth muscle-like cells that commonly carry loss-of-function mutations in either the tuberous sclerosis complex 1 or 2 (TSC1 or TSC2) genes. While allosteric inhibition of the mechanistic target of rapamycin (mTOR) has shown substantial clinical benefit, complementary therapies are required to improve response and/or to treat specific patients. However, there is a lack of LAM biomarkers that could potentially be used to monitor the disease and to develop other targeted therapies. We hypothesized that the mediators of cancer metastasis to lung, particularly in breast cancer, also play a relevant role in LAM. Analyses across independent breast cancer datasets revealed associations between low TSC1/2 expression, altered mTOR complex 1 (mTORC1) pathway signaling, and metastasis to lung. Subsequently, immunohistochemical analyses of 23 LAM lesions revealed positivity in all cases for the lung metastasis mediators fascin 1 (FSCN1) and inhibitor of DNA binding 1 (ID1). Moreover, assessment of breast cancer stem or luminal progenitor cell biomarkers showed positivity in most LAM tissue for the aldehyde dehydrogenase 1 (ALDH1), integrin-beta 3 (ITGB3/CD61), and/or the sex-determining region Y-box 9 (SOX9) proteins. The immunohistochemical analyses also provided evidence of heterogeneity between and within LAM cases. The analysis of Tsc2-deficient cells revealed relative over-expression of FSCN1 and ID1; however, Tsc2-deficient cells did not show higher sensitivity to ID1-based cancer inhibitors. Collectively, the results of this study reveal novel LAM biomarkers linked to breast cancer metastasis to lung and to cell stemness, which in turn might guide the assessment of additional or complementary therapeutic opportunities for LAM.